These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29406907)

  • 1. Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients.
    Cristiano E; Alonso R; Alvez Pinheiro A; Bacile EA; Balbuena ME; Ballario C; Barboza AG; Bestoso S; Burgos M; Cáceres F; Carnero Contentti E; Carrá A; Crespo E; Curbelo MC; Deri N; Fernandez J; Fernández Liguori N; Fiol M; Gaitán MI; Garcea O; Giunta D; Halfon MJ; Hryb JP; Jacobo M; Kohler E; Linares R; Luetic GG; Martínez AD; Míguez J; Nofal PG; Patrucco L; Piedrabuena R; Rojas JI; Rotta Escalante R; Saladino ML; Silva BA; Sinay V; Steinberg JD; Tarulla A; Vétere SA; Villa A; Vrech C; Ysrraelit MC; Correale J
    J Neurol Sci; 2018 Feb; 385():217-224. PubMed ID: 29406907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus recommendations on the management of multiple sclerosis patients in Argentina.
    Cristiano E; Rojas JI; Alonso R; Alvez Pinheiro A; Bacile EA; Balbuena ME; Barboza AG; Bestoso S; Burgos M; Cáceres F; Carnero Contentti E; Curbelo MC; Deri N; Fernandez Liguori N; Gaitán MI; Garcea O; Giunta D; Halfon MJ; Hryb JP; Jacobo M; Kohler E; Luetic GG; Maglio I; Martínez AD; Míguez J; Nofal PG; Patrucco L; Piedrabuena R; Rotta Escalante R; Saladino ML; Silva BA; Sinay V; Tkachuk V; Villa A; Vrech C; Ysrraelit MC; Correale J
    J Neurol Sci; 2020 Feb; 409():116609. PubMed ID: 31816524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Argentinean consensus guidelines on the identification and clinical care of secondary progressive multiple sclerosis].
    Cristiano E; Patrucco L; Ysrraelit MC; Alonso R; Balbuena ME; Ballario C; Barboza AG; Bestoso S; Burgos M; Cáceres FJ; Carrá A; Carnero-Contentti E; Deri N; Fernández-Liguori N; Garcea O; Hryb JP; Jacobo M; Kohler E; Luetic GG; Mainella C; Menichini ML; Míguez J; Nofal PG; Piedrabuena R; Rugilo C; Saladino ML; Silva BA; Silva E; Sinay V; Tavolini D; Tkachuk VA; Villa A; Vrech C; Rojas JI
    Rev Neurol; 2021 Jan; 72(1):23-32. PubMed ID: 33378076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America.
    Cristiano E; Rojas JI; Abad P; Adoni T; Barahona J; Becker J; Carrá A; Flores J; Fruns M; Fernández Liguori N; Garcea O; García Bónito J; Giunta D; Gracia F; Hamuy F; Macias Islas MA; Navas C; Boschetti LO; Patrucco L; Sato DK; Correale J
    J Neurol Sci; 2018 Oct; 393():4-13. PubMed ID: 30096568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentina.
    Liguori NF; Alonso R; Pinheiro AA; Balbuena ME; Barboza A; Bestoso S; Burgos M; Cáceres F; Carnero Contentti E; Carrá A; Cristiano E; Curbelo MC; Deri N; Fiol M; Gaitán MI; Garcea O; Halfon M; Hryb J; Jacobo M; José G; Knorre E; López P; Luetic G; Mainella C; Martínez A; Miguez J; Nofal P; Pagani Cassará F; Marcilla MP; Piedrabuena R; Pita C; Quarracino C; Rojas JI; Silva B; Sinay V; Steinberg J; Tarulla A; Tavolini D; Tkachuk V; Tizio S; Villa A; Vrech C; Ysrraelit C; Patrucco L
    Mult Scler Relat Disord; 2020 Aug; 43():102147. PubMed ID: 32442883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis.
    Alonso R; Eizaguirre MB; López P; Silva B; Rojas JI; Sinay V; Tkachuk V; Patrucco L; Carra A; Bruno D; Pagani Cassara F; Fernández Liguori N; Tavolini D; Camerlingo S; Garcea O; Galiani A; Mainella C; Barboza A; Luetic G; Carnero Contentti E
    Neurol Sci; 2023 Feb; 44(2):667-676. PubMed ID: 36319902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of relapsing-remitting multiple sclerosis in Latin America: practical recommendations for treatment optimization.
    Correale J; Abad P; Alvarenga R; Alves-Leon S; Armas E; Barahona J; Buzó R; Corona T; Cristiano E; Gracia F; Bonitto JG; Macías MA; Soto A; Vizcarra D; Freedman MS
    J Neurol Sci; 2014 Apr; 339(1-2):196-206. PubMed ID: 24607335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementation.
    Cristiano E; Abad P; Becker J; Carrá A; Correale J; Flores J; Fruns M; Garcea O; Garcia Bónitto J; Gracia F; Hamuy F; Navas C; Patrucco L; Rivera V; Velazquez M; Rojas JI
    J Neurol Sci; 2021 Oct; 429():118072. PubMed ID: 34509134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice patterns in multiple sclerosis management: Mexican consensus recommendations.
    Skromne-Eisenberg E; Treviño-Frenk I; Llamosa García Velázquez GL; Quiñones-Aguilar S; Rivas-Alonso V; Maza-Flores M; Macías-Islas MÁ; Llamas-López L; González-Amezquita V; León-Jiménez C; Medina-López Z; Ortiz-Maldonado JF; Santos-Diaz MA; Bertado-Cortés B; Flores-Rivera JJ; Ordóñez-Boschetti L
    Mult Scler Relat Disord; 2021 Aug; 53():103053. PubMed ID: 34139461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS).
    Yamout B; Alroughani R; Al-Jumah M; Goueider R; Dahdaleh M; Inshasi J; Hashem S; Alsharoqi I; Sahraian M; Khoury S; Alkawi Z; Koussa S; Zakaria M; Al Khaburi J; Alsaadi T; Bohlega S
    Curr Med Res Opin; 2015; 31(7):1349-61. PubMed ID: 25946578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for the management of multiple sclerosis relapses.
    Laplaud D; Bodiguel E; Bensa C; Blanc F; Brassat D; Magy L; Ouallet JC; Zephir H; De Seze J;
    Rev Neurol (Paris); 2012 May; 168(5):425-33. PubMed ID: 22555010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis.
    Young PJ; Lederer C; Eder K; Daumer M; Neiss A; Polman C; Kappos L;
    Neurology; 2006 Sep; 67(5):804-8. PubMed ID: 16966541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.
    Coles AJ; Fox E; Vladic A; Gazda SK; Brinar V; Selmaj KW; Bass AD; Wynn DR; Margolin DH; Lake SL; Moran S; Palmer J; Smith MS; Compston DA
    Lancet Neurol; 2011 Apr; 10(4):338-48. PubMed ID: 21397567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.
    Oh J; Gagné-Brosseau MS; Guenette M; Larochelle C; Lemieux F; Menon S; Morrow SA; Poliquin-Lasnier L; Roy-Hewitson C; Rush C; Trudelle AM; Giacomini PS
    Can J Neurol Sci; 2018 May; 45(3):304-312. PubMed ID: 29756588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
    Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incomplete nature of multiple sclerosis relapse resolution.
    Lublin FD
    J Neurol Sci; 2007 May; 256 Suppl 1():S14-8. PubMed ID: 17337274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis.
    Rojas JI; Patrucco L; Miguez J; Besada C; Cristiano E
    Neurol Res; 2014 Jul; 36(7):615-8. PubMed ID: 24620963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.